Literature DB >> 16490572

Neuropsychological profile of cognitively impaired patients with schizophrenia.

Vasilis P Bozikas1, Mary H Kosmidis, Grigoris Kiosseoglou, Athanasios Karavatos.   

Abstract

OBJECTIVE: Our purpose in undertaking the present study was to explore the existence of specific areas of cognitive deficits within the context of generalized poor performance in a group of Greek patients with schizophrenia. We also sought to identify any patients who might be cognitively normal.
METHOD: Participants were 70 patients with schizophrenia and 42 healthy control subjects. The 2 groups were matched on age and male-female ratio but differed in their level of education. A battery of neuropsychological tests was selected to assess executive functions/abstraction, fluency, verbal and spatial working memory, verbal and nonverbal memory, attention, visuospatial ability, and psychomotor speed.
RESULTS: Patients with schizophrenia performed more poorly than healthy control subjects, when we controlled for differences in level of education, on executive functions, working memory, verbal memory, nonverbal memory, fluency, visuospatial ability, and attention. In contrast, no significant differences were found between the 2 groups on psychomotor speed. Patients showed a more pronounced deficit on executive functions, verbal and visual memory, and visuospatial ability. Overall, 13% to 62% of the patients with schizophrenia scored within 1 SD of the mean z scores of healthy control group depending on the cognitive domains examined. In the entire sample of patients with schizophrenia, however, no individual scored within 1 SD of the mean z scores of the control group in all cognitive domains.
CONCLUSIONS: We found a generalized deficit in cognitive functioning in a group of patients with schizophrenia. We failed to find any individual patients who were healthy across all cognitive areas. The current neuropsychological profile, indicating widespread impairment, is comparable to that reported in the international literature and thus appears to be characteristic of schizophrenia. Our findings of increased difficulties with executive functions, verbal and visual memory, and visuospatial ability support previous suggestions of generalized brain dysfunction in the pathophysiology of schizophrenia.

Entities:  

Mesh:

Year:  2006        PMID: 16490572     DOI: 10.1016/j.comppsych.2005.05.002

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  13 in total

1.  Neurobehavioral assessment in forensic practice.

Authors:  George W Woods; David Freedman; Stephen Greenspan
Journal:  Int J Law Psychiatry       Date:  2012-10-09

Review 2.  Mouse pharmacological models of cognitive disruption relevant to schizophrenia.

Authors:  Jared W Young; Susan B Powell; Mark A Geyer
Journal:  Neuropharmacology       Date:  2011-06-29       Impact factor: 5.250

Review 3.  Executive function, neural circuitry, and genetic mechanisms in schizophrenia.

Authors:  Daniel Paul Eisenberg; Karen Faith Berman
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

4.  The volumetric differences of the fronto-temporal region in young offspring of schizophrenic patients.

Authors:  Sahika Gülen Sişmanlar; Yonca Anik; Ayşen Coşkun; Belma Ağaoğlu; Işik Karakaya; Cavit Işik Yavuz
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-08-27       Impact factor: 4.785

5.  Functional implications of neuropsychological normality and symptom remission in older outpatients diagnosed with schizophrenia: A cross-sectional study.

Authors:  Winnie W Leung; Christopher R Bowie; Philip D Harvey
Journal:  J Int Neuropsychol Soc       Date:  2008-05       Impact factor: 2.892

6.  Executive Functions in Students With Depression, Anxiety, and Stress Symptoms.

Authors:  Bita Ajilchi; Vahid Nejati
Journal:  Basic Clin Neurosci       Date:  2017 May-Jun

7.  Cognitive training for schizophrenia in developing countries: a pilot trial in Brazil.

Authors:  Livia M M Pontes; Camila B Martins; Isabel C Napolitano; Juliana R Fonseca; Graça M R Oliveira; Sandra M K Iso; Anny K P M Menezes; Adriana D B Vizzotto; Elaine S di Sarno; Hélio Elkis
Journal:  Schizophr Res Treatment       Date:  2013-10-30

Review 8.  Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models.

Authors:  James N Samsom; Albert H C Wong
Journal:  Front Psychiatry       Date:  2015-02-18       Impact factor: 4.157

9.  Abnormal neural hierarchy in processing of verbal information in patients with schizophrenia.

Authors:  Yulia Lerner; Maya Bleich-Cohen; Shimrit Solnik-Knirsh; Galit Yogev-Seligmann; Tamir Eisenstein; Waheed Madah; Alon Shamir; Talma Hendler; Ilana Kremer
Journal:  Neuroimage Clin       Date:  2017-12-27       Impact factor: 4.881

10.  Cognitive performance of long-term institutionalized elderly patients with schizophrenia: A case control study.

Authors:  Alexandre Paim Diaz; Monica Zavaloni Scalco; Marcelo Libório Schwarzbold; Douglas Affonso Formolo; Alberto Stoppe Júnior
Journal:  Dement Neuropsychol       Date:  2011 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.